ADULT
Clinical trials for ADULT explained in plain language.
Never miss a new study
Get alerted when new ADULT trials appear
Sign up with your email to follow new studies for ADULT, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Experimental cancer therapy trial halted after just two patients
Disease control TerminatedThis early-stage trial tested a treatment that uses a patient's own immune cells (tumor-infiltrating lymphocytes) to attack advanced solid tumors. The goal was to check safety and side effects, but the study was stopped early after enrolling only 2 participants. Because the treat…
Matched conditions: ADULT
Phase: EARLY_PHASE1 • Sponsor: Grit Biotechnology • Aim: Disease control
Last updated May 26, 2026 03:14 UTC
-
Experimental cell therapy for advanced cancers shows early promise but study halted
Disease control TerminatedThis early-phase trial tested a personalized cell therapy called GT101 for people with advanced solid tumors that had spread or come back. The treatment involved collecting immune cells from the patient's own tumor, growing them in a lab, and infusing them back along with chemoth…
Matched conditions: ADULT
Phase: EARLY_PHASE1 • Sponsor: Grit Biotechnology • Aim: Disease control
Last updated May 22, 2026 14:01 UTC
-
Experimental cell therapy tested for advanced lung cancer
Disease control TerminatedThis study tested a personalized treatment called GT201, made from a patient's own immune cells (tumor-infiltrating lymphocytes), for advanced lung cancer. The goal was to see if it was safe and could shrink tumors. Only 2 people took part, and the study was stopped early, so res…
Matched conditions: ADULT
Phase: NA • Sponsor: Grit Biotechnology • Aim: Disease control
Last updated May 20, 2026 11:57 UTC
-
Experimental immune cell therapy tested for advanced gynecological cancers
Disease control TerminatedThis early study tested an experimental therapy called GT201, made from a patient's own immune cells (tumor-infiltrating lymphocytes), for advanced gynecological tumors like cervical cancer. Only 4 people took part, and the main goal was to check safety and side effects. The stud…
Matched conditions: ADULT
Phase: NA • Sponsor: Grit Biotechnology • Aim: Disease control
Last updated May 18, 2026 12:03 UTC
-
Lung cancer cell therapy trial halted after just 2 patients
Disease control TerminatedThis study tested a new treatment for advanced non-small cell lung cancer using a patient's own immune cells (TILs) combined with an immunotherapy drug. The goal was to see if the combination was safe and tolerable. However, the trial was terminated early and only enrolled 2 peop…
Matched conditions: ADULT
Phase: NA • Sponsor: Grit Biotechnology • Aim: Disease control
Last updated May 08, 2026 12:00 UTC
-
Sticker shock: simple reminder aims to cut unnecessary IV antibiotic use
Knowledge-focused TerminatedThis study tested whether placing a sticker reminder on patient charts would encourage doctors to switch from intravenous (IV) to oral fluoroquinolone antibiotics sooner. It involved 168 adults with infections who were receiving IV antibiotics. The study was terminated early, so …
Matched conditions: ADULT
Phase: NA • Sponsor: Mahidol University • Aim: Knowledge-focused
Last updated May 26, 2026 03:16 UTC